La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hypoxia regulation of ATP13A2 (PARK9) gene transcription

Identifieur interne : 001518 ( Main/Exploration ); précédent : 001517; suivant : 001519

Hypoxia regulation of ATP13A2 (PARK9) gene transcription

Auteurs : QIAN XU [Canada, République populaire de Chine] ; HONGLING GUO [Canada] ; XIAOJIE ZHANG [Canada] ; BEISHA TANG [République populaire de Chine] ; FANG CAI [Canada] ; WEIHUI ZHOU [République populaire de Chine] ; WEIHONG SONG [Canada, République populaire de Chine]

Source :

RBID : Pascal:12-0295770

Descripteurs français

English descriptors

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorders with a variable combination of motor and non-motor symptoms. Mutations in several genes including ATP13A2 (PARK9) are reported to be associated with PD. The underlying mechanism of PD is not well defined, however, both genetic and environmental causes contribute to it. ATP13A2 gene locates in chromosome 1 and contains 29 exons encoding for a protein of 1180 amino acids with 10 transmembrane domains. Abnormal gene expression has been implicated in neurodegenerative disorders. The transcriptional regulation of the ATP13A2 gene is unknown. In this report, we cloned and functionally characterized the human ATP13A2 gene promoter. We showed that the promoter region of the human ATP13A2 gene contains hypoxia response elements which can bind to transcription factor hypoxia-inducible factor 1α (HIF-1α). Hypoxia up-regulated ATP13A2 transcription via HIF-1α in HEK293 and dopaminergic MN9D cells. Our study indicates that hypoxia signaling plays a very important role in the regulation of human ATP13A2 gene expression. Further study is needed to determine the role of hypoxia in the pathogenesis of PD and its interaction with other PD causative genes, which will provide insights to the role of hypoxia and dysregulation of gene expression in Parkinson's disease.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Hypoxia regulation of ATP13A2 (PARK9) gene transcription</title>
<author>
<name sortKey="Qian Xu" sort="Qian Xu" uniqKey="Qian Xu" last="Qian Xu">QIAN XU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Xiangya Hospital, Central South University</s1>
<s2>Changsha, Hunan</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Changsha, Hunan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hongling Guo" sort="Hongling Guo" uniqKey="Hongling Guo" last="Hongling Guo">HONGLING GUO</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xiaojie Zhang" sort="Xiaojie Zhang" uniqKey="Xiaojie Zhang" last="Xiaojie Zhang">XIAOJIE ZHANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Beisha Tang" sort="Beisha Tang" uniqKey="Beisha Tang" last="Beisha Tang">BEISHA TANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Xiangya Hospital, Central South University</s1>
<s2>Changsha, Hunan</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Changsha, Hunan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang Cai" sort="Fang Cai" uniqKey="Fang Cai" last="Fang Cai">FANG CAI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Weihui Zhou" sort="Weihui Zhou" uniqKey="Weihui Zhou" last="Weihui Zhou">WEIHUI ZHOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ministry of Education Key Laboratory of Child Development and Disorder, and Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Children's Hospital, Chongqing Medical University</s1>
<s2>Chongqing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Chongqing</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Weihong Song" sort="Weihong Song" uniqKey="Weihong Song" last="Weihong Song">WEIHONG SONG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ministry of Education Key Laboratory of Child Development and Disorder, and Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Children's Hospital, Chongqing Medical University</s1>
<s2>Chongqing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Chongqing</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">12-0295770</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0295770 INIST</idno>
<idno type="RBID">Pascal:12-0295770</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000180</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A72</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000154</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000154</idno>
<idno type="wicri:doubleKey">0022-3042:2012:Qian Xu:hypoxia:regulation:of</idno>
<idno type="wicri:Area/Main/Merge">001568</idno>
<idno type="wicri:Area/Main/Curation">001518</idno>
<idno type="wicri:Area/Main/Exploration">001518</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Hypoxia regulation of ATP13A2 (PARK9) gene transcription</title>
<author>
<name sortKey="Qian Xu" sort="Qian Xu" uniqKey="Qian Xu" last="Qian Xu">QIAN XU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Xiangya Hospital, Central South University</s1>
<s2>Changsha, Hunan</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Changsha, Hunan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hongling Guo" sort="Hongling Guo" uniqKey="Hongling Guo" last="Hongling Guo">HONGLING GUO</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Xiaojie Zhang" sort="Xiaojie Zhang" uniqKey="Xiaojie Zhang" last="Xiaojie Zhang">XIAOJIE ZHANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Beisha Tang" sort="Beisha Tang" uniqKey="Beisha Tang" last="Beisha Tang">BEISHA TANG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Neurology, Xiangya Hospital, Central South University</s1>
<s2>Changsha, Hunan</s2>
<s3>CHN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Changsha, Hunan</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Fang Cai" sort="Fang Cai" uniqKey="Fang Cai" last="Fang Cai">FANG CAI</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Weihui Zhou" sort="Weihui Zhou" uniqKey="Weihui Zhou" last="Weihui Zhou">WEIHUI ZHOU</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ministry of Education Key Laboratory of Child Development and Disorder, and Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Children's Hospital, Chongqing Medical University</s1>
<s2>Chongqing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Chongqing</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Weihong Song" sort="Weihong Song" uniqKey="Weihong Song" last="Weihong Song">WEIHONG SONG</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Townsend Family Laboratories, Department of Psychiatry, Brain Research Center, Graduate Program in Neuroscience, The University of British Columbia</s1>
<s2>Vancouver</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Ministry of Education Key Laboratory of Child Development and Disorder, and Chongqing Key Laboratory of Translational Medical Research in Cognitive Development and Learning and Memory Disorders, Children's Hospital, Chongqing Medical University</s1>
<s2>Chongqing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
<wicri:noRegion>Chongqing</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of neurochemistry</title>
<title level="j" type="abbreviated">J. neurochem.</title>
<idno type="ISSN">0022-3042</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of neurochemistry</title>
<title level="j" type="abbreviated">J. neurochem.</title>
<idno type="ISSN">0022-3042</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Gene</term>
<term>Gene expression</term>
<term>Genetics</term>
<term>Human</term>
<term>Hypoxia</term>
<term>Motor system disorder</term>
<term>Mutation</term>
<term>Oxygen</term>
<term>Parkinson disease</term>
<term>Pathogenesis</term>
<term>Protein</term>
<term>Response element</term>
<term>Signal transduction</term>
<term>Transcription</term>
<term>Transcription factor</term>
<term>Transcription promoter</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Hypoxie</term>
<term>Gène</term>
<term>Transcription</term>
<term>Mutation</term>
<term>Génétique</term>
<term>Protéine</term>
<term>Expression génique</term>
<term>Promoteur transcription</term>
<term>Maladie de Parkinson</term>
<term>Elément réponse</term>
<term>Facteur transcription</term>
<term>Trouble moteur</term>
<term>Transduction signal</term>
<term>Pathogénie</term>
<term>Homme</term>
<term>Oxygène</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Génétique</term>
<term>Homme</term>
<term>Oxygène</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease (PD) is the second most common neurodegenerative disorders with a variable combination of motor and non-motor symptoms. Mutations in several genes including ATP13A2 (PARK9) are reported to be associated with PD. The underlying mechanism of PD is not well defined, however, both genetic and environmental causes contribute to it. ATP13A2 gene locates in chromosome 1 and contains 29 exons encoding for a protein of 1180 amino acids with 10 transmembrane domains. Abnormal gene expression has been implicated in neurodegenerative disorders. The transcriptional regulation of the ATP13A2 gene is unknown. In this report, we cloned and functionally characterized the human ATP13A2 gene promoter. We showed that the promoter region of the human ATP13A2 gene contains hypoxia response elements which can bind to transcription factor hypoxia-inducible factor 1α (HIF-1α). Hypoxia up-regulated ATP13A2 transcription via HIF-1α in HEK293 and dopaminergic MN9D cells. Our study indicates that hypoxia signaling plays a very important role in the regulation of human ATP13A2 gene expression. Further study is needed to determine the role of hypoxia in the pathogenesis of PD and its interaction with other PD causative genes, which will provide insights to the role of hypoxia and dysregulation of gene expression in Parkinson's disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Qian Xu" sort="Qian Xu" uniqKey="Qian Xu" last="Qian Xu">QIAN XU</name>
</noRegion>
<name sortKey="Fang Cai" sort="Fang Cai" uniqKey="Fang Cai" last="Fang Cai">FANG CAI</name>
<name sortKey="Hongling Guo" sort="Hongling Guo" uniqKey="Hongling Guo" last="Hongling Guo">HONGLING GUO</name>
<name sortKey="Weihong Song" sort="Weihong Song" uniqKey="Weihong Song" last="Weihong Song">WEIHONG SONG</name>
<name sortKey="Xiaojie Zhang" sort="Xiaojie Zhang" uniqKey="Xiaojie Zhang" last="Xiaojie Zhang">XIAOJIE ZHANG</name>
</country>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Qian Xu" sort="Qian Xu" uniqKey="Qian Xu" last="Qian Xu">QIAN XU</name>
</noRegion>
<name sortKey="Beisha Tang" sort="Beisha Tang" uniqKey="Beisha Tang" last="Beisha Tang">BEISHA TANG</name>
<name sortKey="Weihong Song" sort="Weihong Song" uniqKey="Weihong Song" last="Weihong Song">WEIHONG SONG</name>
<name sortKey="Weihui Zhou" sort="Weihui Zhou" uniqKey="Weihui Zhou" last="Weihui Zhou">WEIHUI ZHOU</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001518 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001518 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:12-0295770
   |texte=   Hypoxia regulation of ATP13A2 (PARK9) gene transcription
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022